Clinical Trial Update: SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating short-course radiotherapy (SCRT) followed by AK112 in patients with pMMR/MSS mid-low rectal cancer; the study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Rectal Cancer, Radiation | Phase 2 | Status: NOT_YET_RECRUITING